Veterinary CRO And CDMO Market Growth Rate, Size, Share Analysis, Overview By 2033


Posted February 22, 2024 by ravali

Global veterinary cro and cdmo market size is expected to reach $9.87 Bn by 2028 at a rate of 8.9%, segmented as by service type, discovery, development, manufacturing, packaging and labeling, market approval and post-marketing

 
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.

The Veterinary CRO And CDMO Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Veterinary CRO And CDMO Market:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

According to The Business Research Company’s Veterinary CRO And CDMO Global Market Report 2024, The veterinary cro and cdmo market size has grown strongly in recent years. It will grow from $6.44 billion in 2023 to $7.03 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to regulatory compliance needs, globalization of animal health market, increased drug development for livestock, increased outsourcing by pharma companies.The veterinary cro and cdmo market size is expected to see strong growth in the next few years. It will grow to $9.87 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%.

The increase in investments in animal healthcare is expected to drive the growth of the veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market in the future. These investments have been rising due to the growing recognition of the significance of animal health and the expanding demand for veterinary services and products. Consequently, there is a corresponding increase in demand for CRO and CDMO services in the veterinary sector. For example, in 2022, according to a report by the American Pet Products Association (APPA), a US-based non-profit organization promoting pet ownership and the pet products industry, pet care expenditure in the U.S. rose from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. This trend indicates a growing focus on animal healthcare, which is expected to fuel the growth of the veterinary CRO and CDMO market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

The veterinary cro and cdmo market covered in this report is segmented –
1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Top Major Players
Labcorp Drug Development India Private Limited,
Zoetis Inc.,
Eurofins Scientific SE,
Pharmaceutical Product Development Inc.,
Syneos Health Inc.

The veterinary cro and cdmo market report table of contents includes:
1. Executive Summary
2. Veterinary CRO And CDMO Market Characteristics
3. Veterinary CRO And CDMO Market Trends And Strategies
4. Veterinary CRO And CDMO Market - Macro Economic Scenario
5. Global Veterinary CRO And CDMO Market Size and Growth
6. Veterinary CRO And CDMO Market Segmentation
7. Veterinary CRO And CDMO Market Regional And Country Analysis
....................
34. Key Mergers And Acquisitions In The Veterinary CRO And CDMO Market
35. Veterinary CRO And CDMO Market Future Outlook and Potential Analysis
36. Appendix

List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Veterinary CRO And CDMO Market, Segmentation By Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Veterinary CRO And CDMO Market, Segmentation By Animal Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Veterinary CRO And CDMO Market, Segmentation By Application , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
....................
Table 74: Labcorp Drug Development India Private Limited Financial Performance
Table 75: Zoetis Inc. Financial Performance
Table 76: Eurofins Scientific SE Financial Performance
Table 77: Pharmaceutical Product Development Inc. Financial Performance
Table 78: Syneos Health Inc. Financial Performance

Read Related Reports :
https://topprnews.com/osteoporosis-treatment-market-trends/
https://goodprnews.com/osteoporosis-treatment-market-strategies/

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By tbrc
Country United States
Categories Health
Last Updated February 22, 2024